Demystifying NPM1 in AML: What It Means and Why It Matters

Name: Demystifying NPM1 in AML: What It Means and Why It Matters
Start: 2025-07-02T16:00:00-04:00
End: 2025-07-02T17:00:00-04:00

Demystifying NPM1 in AML: What It Means and Why It Matters

Webinar

Jul 02, 2025 / 04:00PM - 05:00PM EDT

videocam

Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Join us for the next session in our AML genetics series as we explore the NPM1 mutation—one of the most common genetic changes found in acute myeloid leukemia (AML). Dr. Shai Shimony, a physician in Medical Oncology at Dana-Farber Cancer Institute, will walk us through what NPM1 is, how it impacts diagnosis and treatment decisions, and why it’s important in understanding your specific type of AML. Whether you’re newly diagnosed or looking to understand your AML journey better, this session will help you feel more informed and confident when speaking with your care team.

Schedule & Agenda

4:00 PM

Introduction

Mary Arnett

Mary introduces the agenda for the event and featured speaker Shai Shimony MD, MPH

4:00 PM

Introduction

Mary Arnett

Mary introduces the agenda for the event and featured speaker Shai Shimony MD, MPH

4:05 PM

Presentation

Shai Shimony MD, MPH

Dr. Shimony talks about NPM1 in AML

4:05 PM

Presentation

Shai Shimony MD, MPH

Dr. Shimony talks about NPM1 in AML

4:35 PM

Questions and Answers

Audience

Type your questions in the chat and we will answer them!

4:35 PM

Questions and Answers

Audience

Type your questions in the chat and we will answer them!

Speakers & Moderators

Mary Arnett

Salt Lake City, UT

Mary joined HealthTree in 2022. She is now the AML & MDS Community and Education Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Read Bio

Shai Shimony MD, MPH

Dr. Noam Shimony is a leukemia specialist with advanced training from Dana-Farber Cancer Institute and a Master’s in Clinical Effectiveness from Harvard. His clinical and research focus centers around improving care and outcomes for patients with acute leukemias, especially AML, ALL, and rare subtypes like BPDCN.

Read Bio

Join the Conversation

This event is part of the Newly Diagnosed group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.